These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

844 related articles for article (PubMed ID: 29111855)

  • 41. Neuritin 1 promotes retinal ganglion cell survival and axonal regeneration following optic nerve crush.
    Sharma TP; Liu Y; Wordinger RJ; Pang IH; Clark AF
    Cell Death Dis; 2015 Feb; 6(2):e1661. PubMed ID: 25719245
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tumor Necrosis Factor Inhibition in the Acute Management of Traumatic Optic Neuropathy.
    Tse BC; Dvoriantchikova G; Tao W; Gallo RA; Lee JY; Pappas S; Brambilla R; Ivanov D; Tse DT; Pelaez D
    Invest Ophthalmol Vis Sci; 2018 Jun; 59(7):2905-2912. PubMed ID: 30025145
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of different neurotrophic factors on the survival of retinal ganglion cells after a complete intraorbital nerve crush injury: a quantitative in vivo study.
    Parrilla-Reverter G; Agudo M; Sobrado-Calvo P; Salinas-Navarro M; Villegas-Pérez MP; Vidal-Sanz M
    Exp Eye Res; 2009 Jun; 89(1):32-41. PubMed ID: 19268467
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Protective Effect of Total Panax Notoginseng Saponins on Retinal Ganglion Cells of an Optic Nerve Crush Injury Rat Model.
    Zhong H; Yu H; Chen B; Guo L; Xu X; Jiang M; Zhong Y; Qi J; Huang P
    Biomed Res Int; 2021; 2021():4356949. PubMed ID: 34395614
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Together JUN and DDIT3 (CHOP) control retinal ganglion cell death after axonal injury.
    Syc-Mazurek SB; Fernandes KA; Wilson MP; Shrager P; Libby RT
    Mol Neurodegener; 2017 Oct; 12(1):71. PubMed ID: 28969695
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intravitreal delivery of human NgR-Fc decoy protein regenerates axons after optic nerve crush and protects ganglion cells in glaucoma models.
    Wang X; Lin J; Arzeno A; Choi JY; Boccio J; Frieden E; Bhargava A; Maynard G; Tsai JC; Strittmatter SM
    Invest Ophthalmol Vis Sci; 2015 Feb; 56(2):1357-66. PubMed ID: 25655801
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vivo effects of single or combined topical neuroprotective and regenerative agents on degeneration of retinal ganglion cells in rat optic nerve crush model.
    Kitamura Y; Bikbova G; Baba T; Yamamoto S; Oshitari T
    Sci Rep; 2019 Jan; 9(1):101. PubMed ID: 30643179
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Topical Treatment With Bromfenac Reduces Retinal Gliosis and Inflammation After Optic Nerve Crush.
    Rovere G; Nadal-Nicolás FM; Sobrado-Calvo P; García-Bernal D; Villegas-Pérez MP; Vidal-Sanz M; Agudo-Barriuso M
    Invest Ophthalmol Vis Sci; 2016 Nov; 57(14):6098-6106. PubMed ID: 27832276
    [TBL] [Abstract][Full Text] [Related]  

  • 49. RGMA and neogenin protein expression are influenced by lens injury following optic nerve crush in the rat retina.
    Schnichels S; Heiduschka P; Julien S
    Graefes Arch Clin Exp Ophthalmol; 2012 Jan; 250(1):39-50. PubMed ID: 21887516
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The role of peroxisome proliferator-activated receptor and effects of its agonist, pioglitazone, on a rat model of optic nerve crush: PPARγ in retinal neuroprotection.
    Zhu J; Zhang J; Ji M; Gu H; Xu Y; Chen C; Hu N
    PLoS One; 2013; 8(7):e68935. PubMed ID: 23874818
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Topical bromfenac transiently delays axotomy-induced retinal ganglion cell loss.
    Rovere G; Nadal-Nicolás FM; Sobrado-Calvo P; Villegas-Pérez MP; Vidal-Sanz M; Agudo-Barriuso M
    Exp Eye Res; 2019 May; 182():156-159. PubMed ID: 30940447
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tumor necrosis factor alpha has an early protective effect on retinal ganglion cells after optic nerve crush.
    Mac Nair CE; Fernandes KA; Schlamp CL; Libby RT; Nickells RW
    J Neuroinflammation; 2014 Nov; 11():194. PubMed ID: 25407441
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ketorolac Administration Attenuates Retinal Ganglion Cell Death After Axonal Injury.
    Nadal-Nicolás FM; Rodriguez-Villagra E; Bravo-Osuna I; Sobrado-Calvo P; Molina-Martínez I; Villegas-Pérez MP; Vidal-Sanz M; Agudo-Barriuso M; Herrero-Vanrell R
    Invest Ophthalmol Vis Sci; 2016 Mar; 57(3):1183-92. PubMed ID: 26975030
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibition of ferroptosis promotes retina ganglion cell survival in experimental optic neuropathies.
    Guo M; Zhu Y; Shi Y; Meng X; Dong X; Zhang H; Wang X; Du M; Yan H
    Redox Biol; 2022 Dec; 58():102541. PubMed ID: 36413918
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Regenerative Responses and Axon Pathfinding of Retinal Ganglion Cells in Chronically Injured Mice.
    Yungher BJ; Ribeiro M; Park KK
    Invest Ophthalmol Vis Sci; 2017 Mar; 58(3):1743-1750. PubMed ID: 28324115
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Interleukin-4 protects retinal ganglion cells and promotes axon regeneration.
    Zuo Z; Fan B; Zhang Z; Liang Y; Chi J; Li G
    Cell Commun Signal; 2024 Apr; 22(1):236. PubMed ID: 38650003
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sigma-1R Protects Retinal Ganglion Cells in Optic Nerve Crush Model for Glaucoma.
    Li L; He S; Liu Y; Yorio T; Ellis DZ
    Invest Ophthalmol Vis Sci; 2021 Aug; 62(10):17. PubMed ID: 34406331
    [TBL] [Abstract][Full Text] [Related]  

  • 58. α-Crystallin protects RGC survival and inhibits microglial activation after optic nerve crush.
    Wu N; Yu J; Chen S; Xu J; Ying X; Ye M; Li Y; Wang Y
    Life Sci; 2014 Jan; 94(1):17-23. PubMed ID: 24220677
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Early downregulation of IGF-I decides the fate of rat retinal ganglion cells after optic nerve injury.
    Homma K; Koriyama Y; Mawatari K; Higuchi Y; Kosaka J; Kato S
    Neurochem Int; 2007 Apr; 50(5):741-8. PubMed ID: 17363111
    [TBL] [Abstract][Full Text] [Related]  

  • 60. RGC death in mice after optic nerve crush injury: oxidative stress and neuroprotection.
    Levkovitch-Verbin H; Harris-Cerruti C; Groner Y; Wheeler LA; Schwartz M; Yoles E
    Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4169-74. PubMed ID: 11095611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 43.